Literature DB >> 17530002

Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies.

C Ferry1, G Gemayel, V Rocha, M Labopin, H Esperou, M Robin, R P de Latour, P Ribaud, A Devergie, T Leblanc, E Gluckman, A Baruchel, G Socié.   

Abstract

We analyzed long-term outcomes and psycho-social aspects in 112 children with malignancies surviving 1 year after hematopoietic stem cell transplantation. At 10 years, overall survival was 75+/-5%, TRM 18+/-4% and relapse 14+/-3%; 10-year cumulative incidence of infections was 31+/-4%, cataract 44+/-4%, pulmonary dysfunction 20+/-4%, bone and joint complications 29+/-5%, hypothyroidism 36+/-4%, cardiac complications 11+/-3% and secondary malignancies 7+/-3%. Total body irradiation (TBI) was the most significant risk factor associated with cataract, pulmonary impairment, osteoarticular complications and hypothyroidism. Chronic graft-versus-host disease was associated with higher incidence of pulmonary dysfunction. The number of complications per patient increased with time. Half of the patients had psychological disturbance, 13 signs of depression and 16 a history of eating behavior disorders; 54% of patients with one or more long-term complications had psychological problems. Sixty-nine patients had learning difficulties and 36 achieved normal scholarship. With increased follow-up, development of late effects and of psycho-social disturbance are of major concern. While the use of single-dose TBI has now been abandoned, other risk factors are still of concern in the early 2000s.

Entities:  

Mesh:

Year:  2007        PMID: 17530002     DOI: 10.1038/sj.bmt.1705710

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  36 in total

1.  PSEUDO-VALUE APPROACH FOR CONDITIONAL QUANTILE RESIDUAL LIFETIME ANALYSIS FOR CLUSTERED SURVIVAL AND COMPETING RISKS DATA WITH APPLICATIONS TO BONE MARROW TRANSPLANT DATA.

Authors:  Kwang Woo Ahn; Brent R Logan
Journal:  Ann Appl Stat       Date:  2016-07-22       Impact factor: 2.083

2.  A randomized clinical trial of a parent-focused social-cognitive processing intervention for caregivers of children undergoing hematopoetic stem cell transplantation.

Authors:  Sharon Manne; Laura Mee; Abraham Bartell; Stephen Sands; Deborah A Kashy
Journal:  J Consult Clin Psychol       Date:  2016-02-25

3.  Second cancer after total-body irradiation (TBI) in childhood.

Authors:  Pascal Pommier; Marie Pierre Sunyach; Caroline Pasteuris; Didier Frappaz; Christian Carrie
Journal:  Strahlenther Onkol       Date:  2009-08       Impact factor: 3.621

4.  Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies.

Authors:  Umberto Ricardi; Andrea Riccardo Filippi; Eleonora Biasin; Patrizia Ciammella; Angela Botticella; Pierfrancesco Franco; Andrea Corrias; Elena Vassallo; Riccardo Ragona; Franca Fagioli
Journal:  Strahlenther Onkol       Date:  2009-08       Impact factor: 3.621

5.  The importance of long-term follow-up in pediatric hematopoietic stem cell transplantation.

Authors:  D A Jacobsohn
Journal:  Bone Marrow Transplant       Date:  2015-04-13       Impact factor: 5.483

6.  Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma.

Authors:  Anne Stone; Danielle Novetsky Friedman; Brian H Kushner; Suzanne Wolden; Shakeel Modak; Michael P LaQuaglia; Jessica Costello; Xian Wu; Nai-Kong Cheung; Charles A Sklar
Journal:  Pediatr Blood Cancer       Date:  2019-08-12       Impact factor: 3.167

7.  NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions.

Authors:  K Scott Baker; Smita Bhatia; Nancy Bunin; Michael Nieder; Christopher C Dvorak; Lillian Sung; Jean E Sanders; Joanne Kurtzberg; Michael A Pulsipher
Journal:  Biol Blood Marrow Transplant       Date:  2011-06-30       Impact factor: 5.742

Review 8.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.

Authors:  Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-19       Impact factor: 5.742

Review 9.  Long-term Effects of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia.

Authors:  Anita Lawitschka; Christina Peters
Journal:  Curr Oncol Rep       Date:  2018-08-03       Impact factor: 5.075

10.  Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy.

Authors:  A S Nelson; L J Ashton; C M Vajdic; R E Le Marsney; B Daniels; I Nivison-Smith; L Wilcox; A J Dodds; T A O'Brien
Journal:  Leukemia       Date:  2014-06-25       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.